[{"AccountsPayableCurrent_0_Q2_USD":13417692.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":19602967.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-49630006.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":-433564.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-237490.0,"OtherLiabilitiesCurrent_0_Q2_USD":17263.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":1616090.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_2_Q2_USD":-419212.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":2404685.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":4584550.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":17463455.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":12971702.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":0.0,"CapitalUnitsAuthorized_0_Q2_shares":150000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":256650727.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":34846599.0,"HeldToMaturitySecuritiesFairValue_0_Q2_USD":242058238.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":33174765.0,"OtherAssetsCurrent_0_Q2_USD":2536284.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":40.7,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":653500.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":82658407.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":2235.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":250478974.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":101653136.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":99359140.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-5424591.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":936353920.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-20269134.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-22746788.0,"DepreciationDepletionAndAmortization_1_Q2_USD":946481.0,"DepreciationDepletionAndAmortization_2_Q2_USD":1781258.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":4331577.0,"EarningsPerShareDiluted_1_Q2_USD":-0.2,"EarningsPerShareDiluted_2_Q2_USD":-0.23,"CapitalizedComputerSoftwareGross_0_Q2_USD":293189.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":850215.0,"HeldToMaturitySecurities_0_Q2_USD":241577133.0,"HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_0_Q2_USD":2000006.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":180523424.0,"PurchaseObligation_0_Q2_USD":72200000.0,"PurchaseObligationDueInSecondYear_0_Q2_USD":32200000.0,"PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_0_Q2_USD":40000000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q2_USD":29443335.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2_Q2_USD":52816951.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q2_USD":1800000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":23528853.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":52983433.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2_Q2_pure":0.918,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2_Q2_pure":0.905,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_Q2_pure":0.018,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_2_Q2_pure":0.005,"ShortTermLeaseCost_1_Q2_USD":0.0,"ShortTermLeaseCost_2_Q2_USD":0.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.089,"OperatingLeaseRightOfUseAsset_0_Q2_USD":10263197.0,"OperatingLeasePayments_2_Q2_USD":600000.0,"OperatingLeasePayments_1_Q2_USD":300000.0,"HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_0_Q2_USD":1518901.0,"HeldToMaturitySecuritiesCurrent_0_Q2_USD":50959058.0,"HeldToMaturitySecuritiesNoncurrent_0_Q2_USD":190618075.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":21800667.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":2661512.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":2590558.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":2521446.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":7.12,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":2256379.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":6933478.0,"LossContingencyAccrualAtCarryingValue_0_Q2_USD":0.0,"OperatingLeaseCost_1_Q2_USD":500000.0,"OperatingLeaseCost_2_Q2_USD":900000.0,"OperatingLeaseLiability_0_Q2_USD":14867189.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":688454.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":14178735.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":936566.0,"VariableLeaseCost_1_Q2_USD":200000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":3111009.0,"OtherAssetsNoncurrent_0_Q2_USD":144150.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-168849557.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-51114395.0,"NetIncomeLoss_1_Q2_USD":-19835570.0,"NetIncomeLoss_2_Q2_USD":-22509298.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":7929100.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":250478974.0,"ProfitLoss_2_Q2_USD":-22509298.0,"ProfitLoss_1_Q2_USD":-19835570.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":29362741.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-441800265.0,"StockholdersEquity_0_Q2_USD":494118658.0,"AccruedLiabilitiesCurrent_0_Q2_USD":4419233.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommonStockSharesAuthorized_0_Q2_shares":145000000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":254810551.0,"DepreciationAndAmortization_2_Q2_USD":2631472.0,"LiabilitiesNoncurrent_0_Q2_USD":14178735.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":561075702.0,"AccountsReceivableNetCurrent_0_Q2_USD":1265771.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-629114.0,"Assets_0_Q2_USD":561075702.0,"AssetsCurrent_0_Q2_USD":314474173.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":256650727.0,"CommonStockSharesIssued_0_Q2_shares":101748107.0,"CommonStockSharesOutstanding_0_Q2_shares":101748107.0,"CommonStockValue_0_Q2_USD":194117.0,"GeneralAndAdministrativeExpense_1_Q2_USD":16325773.0,"GeneralAndAdministrativeExpense_2_Q2_USD":27260330.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-19835570.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-22509298.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":5767770.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":604410.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-46520.0,"LiabilitiesCurrent_0_Q2_USD":53333497.0,"OperatingExpenses_1_Q2_USD":45769108.0,"OperatingExpenses_2_Q2_USD":80077281.0,"OperatingIncomeLoss_1_Q2_USD":-22240255.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":6.31,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":15.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":53.78,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":493563470.0,"EarningsPerShareBasic_1_Q2_USD":-0.2,"EarningsPerShareBasic_2_Q2_USD":-0.23,"FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0_Q2_USD":8561435.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q2_USD":1700429.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":1700429.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":1700429.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":1700429.0,"FurnitureAndFixturesGross_0_Q2_USD":635769.0,"MinorityInterest_0_Q2_USD":-555188.0,"NonoperatingIncomeExpense_1_Q2_USD":2404685.0,"NonoperatingIncomeExpense_2_Q2_USD":4584550.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":14.72,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":4709986.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_Q2_shares":30752.0,"PrepaidExpenseCurrent_0_Q2_USD":3062333.0,"OperatingIncomeLoss_2_Q2_USD":-27093848.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"ShareBasedCompensation_2_Q2_USD":17463455.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":686432.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":1330024.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":4331577.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":67796517.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":101653136.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":13852642.0,"AmortizationOfIntangibleAssets_1_Q2_USD":425107.0,"AmortizationOfIntangibleAssets_2_Q2_USD":850214.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":725481.0,"LeaseholdImprovementsGross_0_Q2_USD":24187465.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":43215383.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":16213366.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":99359140.0,"VariableLeaseCost_2_Q2_USD":300000.0,"Ticker":"ARWR","CIK":"879407","name":"ARROWHEAD PHARMACEUTICALS, INC.","OfficialName":"Arrowhead Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4797362481.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200507"}]